Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy-Reference-Cited by-同舟云学术

Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy

Published:2016-12-07 Issue:4 Volume:6 Page:e1264563
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Ren Jun¹²,Gwin William R.²,Zhou Xinna¹,Wang Xiaoli¹,Huang Hongyan¹,Jiang Ni¹,Zhou Lei¹,Agarwal Pankaj²,Hobeika Amy²,Crosby Erika²,Hartman Zachary C.²,Morse Michael A.³,H. Eng Kevin⁴,Lyerly H. Kim²

Affiliation:

1. Beijing Key Lab for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

2. Department of Surgery, Duke University Medical Center, Durham, NC, USA

3. Department of Medicine, Duke University Medical Center, Durham, NC, USA

4. Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1264563

Reference30 articles.

1. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors

2. Live viruses to treat cancer